Karp, D. D., Pollak, M. N., Cohen, R. B., Eisenberg, P. D., Haluska, P., Yin, D., . . . Gualberto, A. (2009). Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin.
Style de citation ChicagoKarp, Daniel D., et al. Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination With Paclitaxel and Carboplatin. 2009.
Style de citation MLAKarp, Daniel D., et al. Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination With Paclitaxel and Carboplatin. 2009.
Attention : ces citations peuvent ne pas être correctes à 100%.